Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Martin L Marro"'
Autor:
Bárbara Suárez, María Florencia Mascardi, Flavia Noelia Mazzini, M. Ruda Vera, Sebastián Marciano, Paola Casciato, Adrián Narvaez, Leila Haddad, Margarita Anders, Federico Orozco, Ana Jesica Tamaroff, Frank Cook, John Gounarides, Susana Gutt, Adrián Gadano, Celia Mén dez García, Martin L. Marro, Alberto Penas Steinhardt, Julieta Trinks
Publikováno v:
Annals of Hepatology, Vol 28, Iss , Pp 101015- (2023)
Introduction and Objectives: Fungi, archaea and protozoa are the least known members of the gut microbiome, but they could represent a niche for biomarkers discovery to risk-stratify MAFLD patients. This study aimed to identify gut metatranscriptomic
Externí odkaz:
https://doaj.org/article/57c62c97103749109d631284514371a6
Autor:
Jean B. Regard, Tyler J. Harrison, Jake Axford, Laura Axford, Lac Lee, Xianglin Ren, Lin Deng, Aimee Reynolds, Justin Mao, Qian Liu, Anup Patnaik, Evan Cohick, Micah Hollis-Symynkywicz, Sally Loi, Simone Riek, Una McKeever, David Dunstan, MooJe Sung, Nathaniel F. Ware, Alan P. Brown, Lawrence G. Hamann, Jovita Marcinkeviciene, Andrew W. Patterson, Martin L. Marro
Publikováno v:
Biochemical Pharmacology. 209:115418
Autor:
Jean B. Regard, Tyler J. Harrison, Jake Axford, Laura Axford, Lac Lee, Xianglin Ren, Lin Deng, Aimee Reynolds, Justin Mao, Qian Liu, Anup Patnaik, Evan Cohick, Micah Hollis-Symynkywicz, Sally Loi, Simone Riek, David Dunstan, MooJe Sung, Nathaniel F. Ware, Lawrence G. Hamann, Jovita Marcinkeviciene, Andrew W. Patterson, Martin L. Marro
Publikováno v:
SSRN Electronic Journal.
Autor:
Celia Méndez García, Frank Cook, Alberto Penas-Steinhardt, Julieta Trinks, Margarita Anders, John S. Gounarides, Adrián Narvaez, Sebastián Marciano, Nicolás Quiróz, Ana Jesica Tamaroff, Federico Orozco, Susana Gutt, Paola Casciato, Martin L. Marro, Flavia Noelia Mazzini, Leila Haddad, Adrián Gadano, Maria Florencia Mascardi, Marcelo Risk
Publikováno v:
Metabolomics : Official journal of the Metabolomic Society. 17(7)
Non-invasive biomarkers are needed for metabolic dysfunction-associated fatty liver disease (MAFLD), especially for patients at risk of disease progression in high-prevalence areas. The microbiota and its metabolites represent a niche for MAFLD bioma
Autor:
Adrián Gadano, Maria Florencia Mascardi, John S. Gounarides, Federico Orozco, Frank Cook, Margarita Anders, Julieta Trinks, Nicolás Quiróz, Sebastián Marciano, Susana Gutt, Alberto Penas-Steinhardt, Leila Haddad, Marcelo Risk, Adrián Narvaez, Paola Casciato, Celia Méndez García, Ana Jesica Tamaroff, Martin L. Marro, Flavia Noelia Mazzini
Background and AimsNon-invasive biomarkers are urgently needed to identify patients with non-alcoholic fatty liver disease (NAFLD) especially those at risk of disease progression. This is particularly true in high prevalence areas such as Latin Ameri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::806c5820c998be3fe8759b1ea1776384
https://doi.org/10.1101/2020.07.30.20165308
https://doi.org/10.1101/2020.07.30.20165308
Autor:
Leila Haddad, Susana Gutt, Leandra Mansur, Noelia Mazzini Flavia, Sebastián Marciano, Julieta Trinks, M Ruda Vera, Paola Casciato, Alberto Penas Steinhardt, Cook Frank, Federico Orozco, Gounarides John, Adrián Narvaez, Jesica Tamaroff Ana, Martin L. Marro, Florencia Mascardi María, Adrián Gadano, Margarita Anders, Shilpa Pandit, Yanqun Wang, Celia Méndez García
Publikováno v:
Annals of Hepatology, Vol 24, Iss, Pp 100516-(2021)
Background: The gut microbiome represents a niche for biomarkers discovery to risk-stratify MAFLD patients. However, each population may have unique microbiome signatures and studies are needed in Latin America where MAFLD prevalence and severity are
Autor:
Laura Axford, Micah Hollis-Symynkywicz, Jovita Marcinkeviciene, Lac Lee, Julien Papillon, Tyler Harrison, Jean Regard, Xianglin Ren, Lin Deng, Lawrence G. Hamann, Evan Cohick, Sally Loi, Sam Kecman, Martin L. Marro, Natalie Dales, Andrew Patterson, Anup Patnaik
Publikováno v:
Bioorganic & Medicinal Chemistry. 28:115548
Myeloperoxidase (MPO) activity and subsequent generation of hypochlorous acid has been associated with the killing of host-invading microorganisms (e.g. bacteria, viruses, and fungi). However, during oxidative stress, high MPO activity can damage hos
Autor:
Sally Loi, Lac Lee, Jean Regard, Dominique Custeau, Andrew Patterson, Lin Deng, Julien Papillon, Aimee Reynolds, Tyler Harrison, Micah Hollis-Symynkywicz, Jovita Marcinkeviciene, Lawrence G. Hamann, Anup Patnaik, Xianglin Ren, Jutta Blank, Nigel Casson, Laura Axford, Toshiyuki Honda, Lisa Ames, Lihe Zhang, Martin L. Marro
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 367(1)
Myeloperoxidase (MPO) is a leukocyte-derived redox enzyme that has been linked to oxidative stress and damage in many inflammatory states, including cardiovascular disease. We have discovered aminopyridines that are potent mechanism-based inhibitors
Autor:
Victor L. Serebruany, Dominick J. Angiolillo, Hans Jürgen Pfannkuche, Kristine Rose, Martin L. Marro, Mohamed El Mouelhi
Publikováno v:
American Journal of Therapeutics. 17:543-552
A meta-analysis of 29 clinical studies on tegaserod revealed an imbalance of cardiovascular ischemic events in patients treated with drug versus placebo. Because increased platelet activity is known to attribute to cardiovascular events, we examined
Autor:
Oscar A. Roveri, Martin L. Marro, Javier Girardini, Oreste A. Mascaretti, Gerardo O. Danelon, Ernesto G. Mata
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 5:2037-2040
The synthesis and the inhibitory activity against β-lactamase I from Bacillus cereus is described for a new series of 6α-bromo, chloro or fluoro-2β-chloromethyl-2α-methylpenam-3α-carboxylic acids (5a-c) and their corresponding sulfones 6a-c and